Overview

Efficacy and Tolerability of Carbamazepine CR in Diabetic Neuropathy Pain

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The trial is designed to evaluate the efficacy and tolerability of carbamazepine in neuropathic pain in diabetic patients
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Carbamazepine